BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10964188)

  • 1. The use of randomized control trials in complementary therapies: exploring the issues.
    Richardson J
    J Adv Nurs; 2000 Aug; 32(2):398-406. PubMed ID: 10964188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodological issues and complementary therapies: researching intangibles?
    Carter B
    Complement Ther Nurs Midwifery; 2003 Aug; 9(3):133-9. PubMed ID: 12852929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary therapies: evaluating their effectiveness in cancer.
    Hilsden RJ; Verhoef MJ
    Patient Educ Couns; 1999 Oct; 38(2):101-8. PubMed ID: 14528702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. n-of-1 randomized controlled trials: an opportunity for complementary and alternative medicine evaluation.
    Johnston BC; Mills E
    J Altern Complement Med; 2004 Dec; 10(6):979-84. PubMed ID: 15673992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological changes in the evaluation of complementary and alternative medicine: issues raised by Sherman et al. and Hawk et al.
    Redwood D
    J Altern Complement Med; 2002 Feb; 8(1):5-6. PubMed ID: 11890434
    [No Abstract]   [Full Text] [Related]  

  • 7. Complementary and alternative medicine: exploring the gap between evidence and usage.
    Segar J
    Health (London); 2012 Jul; 16(4):366-81. PubMed ID: 22020366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The context and meaning of placebos for complementary medicine.
    Lewith G; Barlow F; Eyles C; Flower A; Hall S; Hopwood V; Walker J
    Forsch Komplementmed; 2009 Dec; 16(6):404-12. PubMed ID: 20090354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness and practice of complementary therapies in hospital and community settings within Essex in the United Kingdom.
    Fewell F; Mackrodt K
    Complement Ther Clin Pract; 2005 May; 11(2):130-6. PubMed ID: 15955295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are positive alternative medical therapy trials credible?: Evidence from four high-impact medical journals.
    Barker Bausell R
    Eval Health Prof; 2009 Dec; 32(4):349-69. PubMed ID: 19815600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefining the randomized controlled trial in the context of acupuncture research.
    Walji R; Boon H
    Complement Ther Clin Pract; 2006 May; 12(2):91-6. PubMed ID: 16648085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing complementary and alternative therapies within a research protocol.
    Walker LG; Anderson J
    Eur J Cancer; 1999 Oct; 35(11):1614-8. PubMed ID: 10673971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The placebo effect.
    Watson R
    J Clin Nurs; 2006 May; 15(5):519. PubMed ID: 16629958
    [No Abstract]   [Full Text] [Related]  

  • 14. N-of-1 trials: innovative methods to evaluate complementary and alternative medicines in pediatric cancer.
    Sung L; Feldman BM
    J Pediatr Hematol Oncol; 2006 Apr; 28(4):263-6. PubMed ID: 16679928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cochrane for CAM providers: evidence for action.
    Manheimer E; Berman B
    Altern Ther Health Med; 2003; 9(5):110-2. PubMed ID: 14526717
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidenced based medicine. Benefits, limitations and issues for complementary and alternative medicine.
    Mendel J
    Aust J Holist Nurs; 2004 Oct; 11(2):21-9. PubMed ID: 19175254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complementary and alternative medical therapies.
    Schachter SC
    Curr Opin Neurol; 2008 Apr; 21(2):184-9. PubMed ID: 18317278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodological quality of patient-reported outcome research was low in complementary and alternative medicine in oncology.
    Efficace F; Horneber M; Lejeune S; Van Dam F; Leering S; Rottmann M; Aaronson NK
    J Clin Epidemiol; 2006 Dec; 59(12):1257-65. PubMed ID: 17098568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Planning a cluster randomized controlled trial: methodological issues.
    Christie J; O'Halloran P; Stevenson M
    Nurs Res; 2009; 58(2):128-34. PubMed ID: 19289934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodological considerations for future controlled influenza treatment trials in complementary and alternative medicine.
    Kirkby R; Calabrese C; Kaltman L; Monnier J; Herscu P
    J Altern Complement Med; 2010 Mar; 16(3):275-83. PubMed ID: 20192912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.